Pieces Technologies' Clinical AI Systems Allegedly Marketed With Misleading Performance Claims

The Texas Attorney General announced a settlement with Pieces Technologies following allegations that the company misrepresented the accuracy of its healthcare AI systems used for clinical documentation. The state concluded that marketing claims about low error and hallucination rates may have misled hospitals and clinicians relying on the tools in patient care settings. The settlement imposed restrictions on future claims and required greater transparency around performance and risk.